Financial Information

Latest Financial Results

$317M

Total revenue of $317.0 million, up 40% from $227.1 million for the prior-year quarter

$26M

Net income attributable to ApolloMed of $26.0 million, compared to $34.3 million for the prior-year quarter

$0.56

Earnings per share - diluted ("EPS - diluted") of $0.56, compared to $0.74 per share for the prior-year quarter

For complete information regarding our financials, see our periodic filings

View the Latest Financials

Balance Sheet

Includes Current Assets, Liabilities and Stockholder's Equity

View Balance Sheet

Income Statement

Includes Total Net Sales, Cost & Expenses and Earnings per share

View Income Statement

Cash Flows

Includes Net Income, Adjustments, and Cash flows from investing & financing activities

View Cash Flow